Your email has been successfully added to our mailing list.

×
0 0 0.000205409106470395 -0.0013009243409791 -0.00335501540568305 -0.000616227319411184 -0.000890106128038312 -0.00349195480999651
Stock impact report

Coya Therapeutics GAAP EPS of -$0.79 [Seeking Alpha]

Dr. Reddy's Laboratories Ltd (RDY) 
US:NYSE Investor Relations: drreddys.com/investors
Company Research Source: Seeking Alpha
As of December 31, 2023, Coya had cash and cash equivalents of $32.6 million and received an additional $7.5 million in January from Dr. Reddy's as an upfront payment as part of the COYA 302 licensing arrangement. Recommended For You More Trending News About COYA Stock Related Stocks Trending Analysis Trending News Show less Read more
Impact Snapshot
Event Time:
RDY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
RDY alerts

from News Quantified
Opt-in for
RDY alerts

from News Quantified